METRONIDAZOLE IN PREVENTION OF CHOLESTASIS ASSOCIATED WITH TOTAL PARENTERAL NUTRITION
- 1 February 1983
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 321 (8322), 446-447
- https://doi.org/10.1016/s0140-6736(83)91442-3
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Hepatic Alterations During Total Parenteral Nutrition in Patients with Inflammatory Bowel pisease: A Possible Consequence of Lithocholate ToxicityGastroenterology, 1982
- Hepatic Steatosis After Intestinal Bypass—Prevention and Reversal by Metronidazole, Irrespective of Protein-Calorie MalnutritionGastroenterology, 1982
- HEPATIC ALTERATIONS DURING TOTAL PARENTERAL-NUTRITION IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE - A POSSIBLE CONSEQUENCE OF LITHOCHOLATE TOXICITY1982
- Hepatobiliary Dysfunction in Infants and Children Associated with Long-term Total Parenteral Nutrition. A Clinico-pathologic StudyAmerican Journal of Clinical Pathology, 1981
- MetronidazoleNew England Journal of Medicine, 1980
- A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITYThe Lancet, 1980
- Intestinal bacterial metabolism of protein and bile acids: Role in pathogenesis of hepatic disease after jejuno-ileal bypass surgeryBritish Journal of Surgery, 1979
- Liver function values in adults receiving total parenteral nutritionJAMA, 1979
- Artifactual Depression of Serum Glutamic Oxaloacetic Transaminase by MetronidazoleAntimicrobial Agents and Chemotherapy, 1978
- Bile acids, liver injury, and liver diseaseArchives of Internal Medicine, 1972